NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 14, 2025 $2.04 -4.24% $2.43 X 83.94% 0
Aug 14, 2025 $2.06 -3.35% $2.43 X 84.72% 0
Aug 14, 2025 $2.30 +10.05% $2.43 V 94.65% 1
Aug 12, 2025 $1.91 -2.60% $2.09 X 91.34% 0
Aug 12, 2025 $1.93 -1.63% $2.09 X 92.26% 0
Aug 12, 2025 $2.10 +7.14% $2.09 V 99.52% 5
Aug 8, 2025 $2.00 +8.70% $1.90 V 94.74% 1
Aug 7, 2025 $1.93 +2.82% $1.84 X 94.94% 0
Aug 7, 2025 $1.91 +1.76% $1.84 X 96.02% 0
Aug 7, 2025 $2.02 +7.45% $1.84 X 90.22% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE